Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence

The azole antifungal fluconazole possesses only fungistatic activity in Candida albicans and, therefore, this human pathogen is tolerant to this agent. However, tolerance to fluconazole can be inhibited when C. albicans is exposed to fluconazole combined with the immunosuppressive drug cyclosporin A, which is known to inhibit calcineurin activity in yeast. A mutant lacking both alleles of a gene encoding the calcineurin A subunit (CNA) lost viability in the presence of fluconazole, thus making calcineurin essential for fluconazole tolerance. Consistent with this observation, tolerance to fluconazole was modulated by calcium ions or by the expression of a calcineurin A derivative autoactivated by the removal of its C‐terminal inhibitory domain. Interestingly, CNA was also essential for tolerance to other antifungal agents (voriconazole, itraconazole, terbinafine, amorolfine) and to several other metabolic inhibitors (caffeine, brefeldin A, mycophenolic acid, fluphenazine) or cell wall‐perturbing agents (SDS, calcofluor white, Congo red), thus indicating that the calcineurin pathway plays an important role in the survival of C. albicans in the presence of external growth inhibitors. Several genes, including PMC1, a vacuolar calcium P‐type ATPase, were regulated in a calcineurin‐ and fluconazole‐dependent manner. However, PMC1 did not play a direct role in the survival of C. albicans when exposed to fluconazole. In addition to these different properties, calcineurin was found to affect colony morphology in several media known to modulate the C. albicans dimorphic switch. In particular, calcineurin was found to be essential for C. albicans viability in serum‐containing media. Finally, calcineurin was found to be necessary for the virulence of C. albicans in a mice model of infection, thus making calcineurin an important element for adequate adaptation to the conditions of the host environment.

[1]  S. Katiyar,et al.  Antifungal activity in Saccharomyces cerevisiae is modulated by calcium signalling , 2002, Molecular microbiology.

[2]  D. Botstein,et al.  Genome-wide Analysis of Gene Expression Regulated by the Calcineurin/Crz1p Signaling Pathway in Saccharomyces cerevisiae * , 2002, The Journal of Biological Chemistry.

[3]  Dominique Sanglard,et al.  Resistance of human fungal pathogens to antifungal drugs. , 2002, Current opinion in microbiology.

[4]  J. Konopka,et al.  Septin function in Candida albicans morphogenesis. , 2002, Molecular biology of the cell.

[5]  K. Cunningham,et al.  Essential role of calcineurin in response to endoplasmic reticulum stress , 2002, The EMBO journal.

[6]  M. Cyert,et al.  Calcineurin-dependent regulation of Crz1p nuclear export requires Msn5p and a conserved calcineurin docking site. , 2002, Genes & development.

[7]  D. Sanglard,et al.  A common drug‐responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance , 2002, Molecular microbiology.

[8]  Joseph Heitman,et al.  Calcineurin is essential for survival during membrane stress in Candida albicans , 2002, The EMBO journal.

[9]  M. Cyert,et al.  Internal Ca2+ release in yeast is triggered by hypertonic shock and mediated by a TRP channel homologue , 2002, The Journal of cell biology.

[10]  D. Sanglard,et al.  Current understanding of the modes of action and resistance mechanisms to conventional and emerging antifungal agents for treatment of Candida infections. , 2002 .

[11]  D. Botstein,et al.  Genome-wide Analysis of Gene Expression Regulated by the Calcineurin / Crz 1 p Signaling Pathway in Saccharomyces cerevisiae * , 2002 .

[12]  H. Liu,et al.  Transcriptional control of dimorphism in Candida albicans. , 2001, Current opinion in microbiology.

[13]  L. A. Simeoni,et al.  Evidence for Multidrug Resistance-1 P-Glycoprotein-dependent Regulation of Cellular ATP Permeability , 2001, The Journal of Membrane Biology.

[14]  M. Cyert,et al.  Calcineurin-dependent nuclear import of the transcription factor Crz1p requires Nmd5p , 2001, The Journal of cell biology.

[15]  J. Heitman,et al.  Calcineurin is required for hyphal elongation during mating and haploid fruiting in Cryptococcus neoformans , 2001, The EMBO journal.

[16]  J. Heitman,et al.  Calcineurin regulatory subunit is essential for virulence and mediates interactions with FKBP12–FK506 in Cryptococcus neoformans , 2001, Molecular microbiology.

[17]  M. Cyert,et al.  Genetic analysis of calmodulin and its targets in Saccharomyces cerevisiae. , 2001, Annual review of genetics.

[18]  D. Sanglard,et al.  Fluconazole plus Cyclosporine: a Fungicidal Combination Effective against Experimental Endocarditis Due to Candida albicans , 2000, Antimicrobial Agents and Chemotherapy.

[19]  D. Sanglard,et al.  Potent Synergism of the Combination of Fluconazole and Cyclosporine in Candida albicans , 2000, Antimicrobial Agents and Chemotherapy.

[20]  P. Mertz,et al.  Calcineurin: form and function. , 2000, Physiological reviews.

[21]  J. Heitman,et al.  Immunosuppressive and Nonimmunosuppressive Cyclosporine Analogs Are Toxic to the Opportunistic Fungal Pathogen Cryptococcus neoformans via Cyclophilin-Dependent Inhibition of Calcineurin , 2000, Antimicrobial Agents and Chemotherapy.

[22]  T. C. White,et al.  The Trailing End Point Phenotype in Antifungal Susceptibility Testing Is pH Dependent , 1999, Antimicrobial Agents and Chemotherapy.

[23]  M. Cyert,et al.  Yeast calcineurin regulates nuclear localization of the Crz1p transcription factor through dephosphorylation. , 1999, Genes & development.

[24]  T. Walsh,et al.  Antimicrobial peptides as potential new antifungals. , 1999, Mycoses.

[25]  J. Heitman,et al.  Calcineurin , 2007, Cell Biochemistry and Biophysics.

[26]  T. C. White,et al.  Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance , 1998, Clinical Microbiology Reviews.

[27]  W. Niczyporuk,et al.  Effects of cyclosporin A on mycelial transformation of Candida albicans cells in human serum , 1998, Journal of the European Academy of Dermatology and Venereology : JEADV.

[28]  M. Cyert,et al.  Temperature-Induced Expression of YeastFKS2 Is under the Dual Control of Protein Kinase C and Calcineurin , 1998, Molecular and Cellular Biology.

[29]  F. Dromer,et al.  Antifungal drug resistance in pathogenic fungi. , 1998, Medical mycology.

[30]  M. Cyert,et al.  Calcineurin acts through the CRZ1/TCN1-encoded transcription factor to regulate gene expression in yeast. , 1997, Genes & development.

[31]  D. Matheos,et al.  Tcn1p/Crz1p, a calcineurin-dependent transcription factor that differentially regulates gene expression in Saccharomyces cerevisiae. , 1997, Genes & development.

[32]  J. Smith,et al.  In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872) , 1997, Antimicrobial agents and chemotherapy.

[33]  A. Mitchell,et al.  Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors , 1997, Antimicrobial agents and chemotherapy.

[34]  H. Prokisch,et al.  Impairment of calcineurin function in Neurospora crassa reveals its essential role in hyphal growth, morphology and maintenance of the apical Ca2+ gradient , 1997, Molecular and General Genetics MGG.

[35]  H. Tabuchi,et al.  Cloning of the Candida albicans homolog of Saccharomyces cerevisiae GSC1/FKS1 and its involvement in beta-1,3-glucan synthesis , 1997, Journal of bacteriology.

[36]  J. Heitman,et al.  Calcineurin is required for virulence of Cryptococcus neoformans , 1997, The EMBO journal.

[37]  J. Mulholland,et al.  An essential role of the yeast pheromone-induced Ca2+ signal is to activate calcineurin. , 1997, Molecular biology of the cell.

[38]  D. Sanglard,et al.  Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. , 1997, Microbiology.

[39]  D. Sanglard,et al.  Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors , 1996, Antimicrobial agents and chemotherapy.

[40]  R. Bressan,et al.  Activated Calcineurin Confers High Tolerance to Ion Stress and Alters the Budding Pattern and Cell Morphology of Yeast Cells* , 1996, The Journal of Biological Chemistry.

[41]  K. Kuchler,et al.  Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters , 1995, Antimicrobial agents and chemotherapy.

[42]  M. Cyert,et al.  Calcineurin, the Ca2+/calmodulin-dependent protein phosphatase, is essential in yeast mutants with cell integrity defects and in mutants that lack a functional vacuolar H(+)-ATPase , 1995, Molecular and cellular biology.

[43]  B. Chaudhuri,et al.  The interaction between the catalytic A subunit of calcineurin and its autoinhibitory domain, in the yeast two‐hybrid system, is disrupted by cyclosporin A and FK506 , 1995, FEBS letters.

[44]  A. Brown,et al.  Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans , 1994, Molecular microbiology.

[45]  T. Toda,et al.  A calcineurin-like gene ppb1+ in fission yeast: mutant defects in cytokinesis, cell polarity, mating and spindle pole body positioning. , 1994, Journal of cell science.

[46]  J. Heitman,et al.  Calcineurin is essential in cyclosporin A- and FK506-sensitive yeast strains. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[47]  G. Fink,et al.  Calcineurin-dependent growth control in Saccharomyces cerevisiae mutants lacking PMC1, a homolog of plasma membrane Ca2+ ATPases , 1994, The Journal of cell biology.

[48]  D. Irwin,et al.  Isogenic strain construction and gene mapping in Candida albicans. , 1993, Genetics.

[49]  M. Laverdière,et al.  A NEW TYPE OF PENICILLIN RESISTANCE OF STAPHYLOCOCCUS AUREUS , 1977, The Lancet.